IMAGING, FOLLOW-UP & LABORATORY DATA
ROOT HEALTH includes large-scale imaging, outpatient follow-up, and laboratory data collected across the longitudinal NSCLC care pathway. The sections below retain the counts and metrics summarized in the current ROOT HEALTH workbook.
Cohort definition: 38,154 patients with NSCLC, excluding stage 0,
who received cancer-directed treatment at Samsung Medical Center.
Data cutoff: September 18, 2026.
Imaging Data
Number of imaging examinations available in ROOT HEALTH.
| Imaging Modality | No. of Examinations |
|---|---|
| Chest CT | 500,919 |
| Brain MRI | 117,756 |
| PET | 73,637 |
| Total imaging examinations | 692,312 |
OPD Follow-up
Outpatient follow-up volume for the ROOT HEALTH NSCLC cohort.
38,154
Patients with OPD follow-up
1,298,103
Total OPD visits
34.0
Mean OPD visits per patient
Laboratory Tests
Laboratory tests performed after NSCLC diagnosis.
| Laboratory Test | No. of Tests Performed |
|---|---|
| ALC (Absolute Lymphocyte Count) | 802,042 |
| ALP (Alkaline Phosphotase) | 799,860 |
| ALT | 876,286 |
| ANC (Absolute Neutrophil Count) | 828,496 |
| APTT | 129,675 |
| AST | 876,318 |
| Albumin | 863,272 |
| BUN (Blood Urea Nitrogen) | 867,210 |
| Bilirubin, Total | 782,788 |
| CEA | 154,349 |
| CRP (C-Reactive Protein) | 371,595 |
| Ca, Total, Serum (Calcium) | 718,510 |
| Cl, Serum (Chloride) | 668,964 |
| Creatinine | 867,427 |
| Estimated GFR | 862,517 |
| Hemoglobin, Blood | 911,562 |
| K, Serum (Potassium) | 668,964 |
| LD, Serum (Lactate Dehydrogenase) | 253,095 |
| Mg (Magnesium) | 190,990 |
| Na, Serum (Sodium) | 668,964 |
| P, Serum (Phosphorous) | 750,730 |
| PT(INR) | 136,475 |
| Platelet Count, Blood | 911,563 |
| Protein, Total | 775,916 |
| WBC Count, Blood | 911,565 |
| Total laboratory tests | 16,649,133 |
Laboratory Summary
37,920
Patients with post-diagnosis laboratory tests
439.1
Mean laboratory tests per patient
Laboratory test counts represent tests performed after NSCLC diagnosis (N = 37,920 patients).
Back to Data